Posted on April 6, 2011, 6 a.m. in
A major milestone in microfluidics could soon lead to stand-alone, self-powered chips that can diagnose diseases within minutes. The device, developed by an international team of researchers from the University of California, Berkeley, Dublin City University in Ireland and Universidad de Valparaíso Chile, is able to process whole blood samples without the use of external tubing and extra components. The researchers have dubbed the device SIMBAS, which stands for Self-powered Integrated Microfluidic Blood Analysis System.
Ivan K. Dimov, Lourdes Basabe-Desmonts, Jose L. Garcia-Cordero, Benjamin M. Ross, Antonio J. Ricco, Luke P. Lee. “Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS).” Lab Chip, 2011, 11, 845-850.
Health Headlines MORE »
The amount of choline needed by people varies significantly and is dependent upon their gender, life stage, race and ethnicity.
People who develop diabetes and high blood pressure in middle-age are at increased risk of brain damage and problems with thinking skills later in life.
Currently available drugs may help women at high risk of breast and ovarian cancers avoid the need for radical preventive surgery.
People who experience chronic sleep disturbances may be at risk of developing dementia and Alzheimer’s disease at an earlier age.
Bariatric surgery can dramatically reduce an obese person's risk of all-cause mortality and nearly halve their risk of heart attack and stroke.
Compounds in peaches may inhibit the growth of breast cancer cells and their ability to spread.
Older people who have above-average muscle mass also have a significantly lower risk of dying from all-causes.
Chemotherapy may accelerate molecular aging to the equivalent to 15-years of normal aging.
Long after compulsory schooling ends, education continues to enhance cognitive functions.
A self-rated poor level of fitness in a person’s 50s may predict onset of dementia within the next three decades.